Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

November 14, 2018 admin CEO Interview, Healthcare Comments Off on Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

 

 

 

 

 

 

 

 

 

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company's cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.

This content is available to members only.

If you are an existing member, please LOGIN

Not a member? Sign up for a FREE trial account now ($49 per month value), and get immediate access.

Register New Account

Free Membership

.

Institutional / team access subscriptions, contact Melissa Walters 212-871-2057 ext 2
subscribe@wallstreetreporter.com.




Related Articles

Healthcare

Hoth Therapeutics (NASDAQ: HOTH) to Present at the H.C. Wainwright 21st Annual Global Investment Conference and RESI 2019 Boston Conference

September 6, 2019 admin Healthcare, Newsmakers Comments Off on Hoth Therapeutics (NASDAQ: HOTH) to Present at the H.C. Wainwright 21st Annual Global Investment Conference and RESI 2019 Boston Conference

NEW YORK, Sept. 6, 2019  — Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company focused on unique targeted therapeutics for patients suffering from indications such as atopic dermatitis–also known as eczema–as well as dermatological and chronic wound disorders, […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
Newsmakers

MEDNAX (NYSE: MD) Announces Acquisition of Leading Texas Radiology Practice

April 24, 2018 admin Newsmakers Comments Off on MEDNAX (NYSE: MD) Announces Acquisition of Leading Texas Radiology Practice

FORT LAUDERDALE, Fla.—-MEDNAX, Inc. (NYSE:MD), today announced the acquisition of Women’s Radiology Associates, LLP, a private radiology physician group based in Houston. The practice will integrate with Synergy Radiology Associates, a MEDNAX-affiliated physician practice, also […]

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
CEO Interview

Trulieve Cannabis (OTC: TCNNF) Largest Medical Cannabis Co. In Florida

October 9, 2018 admin CEO Interview, Consumer Comments Off on Trulieve Cannabis (OTC: TCNNF) Largest Medical Cannabis Co. In Florida

Trulieve Cannabis (OTC: TCNNF) Largest Medical Cannabis Co. In Florida with 80,000 patients. CEO Interview with Kim Rivers Add to my social media sitesSubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati

Add to my social media sites
SubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati